Cargando…

Very Severe and Refractory Noninfectious Cystitis in Patients with Systemic Lupus Erythematosus: Potential Role of Rituximab Therapy

Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease with various clinical manifestations, including, rarely, a form of interstitial cystitis (lupus cystitis, LC). LC can be asymptomatic and usually has discrete symptoms that improve with conventional therapies available f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ocampo-Piraquive, Vanessa, Mondragón-Lenis, Inés, De los Rios, Juan G., Cañas, Carlos A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936892/ https://www.ncbi.nlm.nih.gov/pubmed/33728086 http://dx.doi.org/10.1155/2021/6610111

Ejemplares similares

Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus
por: Bonilla-Abadía, Fabio, et al.
Publicado: (2014)

Noninfectious Causes of Fever in 128 Patients with Systemic Lupus Erythematosus
por: GUO, Feng, et al.
Publicado: (2019)

Rituximab in the treatment of extensive and refractory subacute cutaneous lupus erythematosus
por: Penha, Mariana Álvares, et al.
Publicado: (2018)

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Patients with Systemic Lupus Erythematosus
por: Atay, Didem, et al.
Publicado: (2012)

Refractory Orbital Myositis in Systemic Lupus Erythematosus A Role for Rituximab
por: Rodrigues Morais, Joana, et al.
Publicado: (2021)

Rituximab for refractory granulomatous eye disease
por: Lower, Elyse E, et al.
Publicado: (2012)

Lupus cystitis: An unusual presentation of systemic lupus erythematosus
por: Mukhopadhyay, S., et al.
Publicado: (2014)

Subacute cutaneous lupus erythematosus versus discoid lupus erythematosus: A challenging diagnosis
por: Kleitsch, Julianne, et al.
Publicado: (2023)

Systemic lupus erythematosus of the urinary tract: focus on lupus cystitis
por: Liberski, Sławomir, et al.
Publicado: (2018)

Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
por: Myung, Jane S, et al.
Publicado: (2010)

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
por: Petricca, Luca, et al.
Publicado: (2020)

Two complications in patients with systemic lupus erythematosus: lupus cystitis and lupus enteritis
por: Wang, Gang, et al.
Publicado: (2022)

Drug-induced subacute cutaneous lupus erythematosus in previously diagnosed systemic lupus erythematosus patients: A case series
por: Keyes, Emily, et al.
Publicado: (2021)

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
por: Tanaka, Yoshiya, et al.
Publicado: (2016)

Multicenter Retrospective Analysis of the Effectiveness and Safety of Rituximab in Korean Patients with Refractory Systemic Lupus Erythematosus
por: Bang, So-Young, et al.
Publicado: (2012)

Hemodialysis Tunneled Catheter Noninfectious Complications
por: Miller, Lisa M., et al.
Publicado: (2016)

Refractory Bullous Systemic Lupus Erythematosus Successfully Treated with Rituximab: A Case Report and Literature Review
por: Ratanapokasatit, Yanisa, et al.
Publicado: (2023)

Neuropsychiatric involvement in systemic lupus erythematosus: A case series
por: Gupta, Nishtha, et al.
Publicado: (2021)

Thalidomide and discoid lupus erythematosus: case series and review of literature
por: Malara, Giovanna, et al.
Publicado: (2022)

Efficacy and safety of rituximab biosimilar in refractory lupus
por: Pongtarakulpanit, Nantakarn, et al.
Publicado: (2020)

Rituximab therapy for juvenile-onset systemic lupus erythematosus
por: Nwobi, Obioma, et al.
Publicado: (2007)

Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
por: Martínez-Pérez, R, et al.
Publicado: (2010)

Efficacy of Rituximab in a Systemic Lupus Erythematosus Patient Presenting with Diffuse Alveolar Hemorrhage
por: Montes-Rivera, Gabriela, et al.
Publicado: (2017)

Incidental retinal vascular occlusions on hydroxychloroquine screening in patients with systemic lupus erythematosus
por: Bajwa, Asima, et al.
Publicado: (2015)

Subacute cutaneous lupus erythematosus induced by gemcitabine in 2 patients with pancreatic cancer
por: Cornacchia, Matthew A., et al.
Publicado: (2019)

Analysis of rituximab’s usage for the treatment of pediatric systemic lupus erythematosus
por: Alves, Alessandra, et al.
Publicado: (2014)

Thrombotic thrombocytopenic purpura treated with rituximab in systemic lupus erythematosus
por: Karimifar, Mansoor
Publicado: (2012)

Off-label use of rituximab for systemic lupus erythematosus in Europe
por: Rydén-Aulin, Monica, et al.
Publicado: (2016)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

Atypical Presenting Symptoms of Acute Onset Systemic Lupus Erythematosus with Enteritis and Cystitis
por: Yagita, Mayu, et al.
Publicado: (2016)

Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results
por: Kraaij, Tineke, et al.
Publicado: (2020)

Noninfectious, Severe Cryoglobulinemic Vasculitis with Renal Involvement – Safety and Efficacy of Long-Term Treatment with Rituximab
por: Leśniak, Ksymena, et al.
Publicado: (2021)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
por: Trachana, M, et al.
Publicado: (2011)

A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus
por: Ishikawa, Yuichi, et al.
Publicado: (2018)

A modified regimen of low-dose rituximab therapy for patients with refractory immune thrombocytopenia associated with systemic lupus erythematosus
por: Zhang, Shuo, et al.
Publicado: (2021)

Non-coronary cardiac manifestations of systemic lupus erythematosus in adults: a comparative study
por: Sayhi, Sameh, et al.
Publicado: (2019)

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
por: McCarthy, Eoghan M, et al.
Publicado: (2018)

Talaromyces marneffei Infection in Systemic Lupus Erythematosus Patients: Report of Two Cases and Review of the Literature
por: Wei, Jingshan, et al.
Publicado: (2020)

Diffuse Facial Hyperpigmentation as a Presenting Sign of Lupus Erythematosus: Three Cases and Review of the Literature
por: Azrielant, Shir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8vi5697e52bfqk7du5c10qb58m